ArticleCancers2021

Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer.

Santosh Renuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.